Self-injuryNCT07281365
Pilot Trial of an Emotion Regulation and Executive Functioning Intervention for Self-Injurious Thoughts and Behaviors (SITBs) in Children
A study testing Treatment as usual (TAU) and Preadolescent SITB Intervention in people with Self-injury and Suicidal Ideation and Behavior, run by University of Colorado, Denver at 1 site in United States.
Trial summary
The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs). The main questions it aims to answer are: 1. Are the recruitment targets and study design feasible? 2. Read more about this study
- Who is it for?
- Ages 7 to 12 years
- Conditions the study is for
- Self-injury, Suicidal Ideation and Behavior, Executive Functioning
- What is being tested?
- Treatment as usual (TAU) and Preadolescent SITB Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2026to May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- between the ages of 7-12
- at least one caregiver/legal guardian able to participate (more permitted)
- experienced at least one episode of SITBs within the last month
- ability to attend weekly sessions in-person or via telehealth
- ability to attend baseline and post-treatment assessments in-person.
- estimated verbal IQ of 70 or greater
Who cannot join
- symptoms interfering with ability to participate in assessments/therapy (i.e., psychosis)
- estimated verbal IQ<70 or previous diagnosis of intellectual development disorder
- requiring inpatient psychiatric stabilization or high-intensity intervention to prevent hospitalization
- active substance use
- ward of the state
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Children's Hospital Colorado
Aurora, Colorado, 80045
Sarah Kennedy, PhD, 303-724-6458, sarah.kennedy@cuanschutz.edu
Sarah M Kennedy, PhD
About this study
Official title: Proof-of-Concept Trial of an Emotion Regulation and Executive Functioning Intervention for SITBs in Children
The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs).
The main questions it aims to answer are:
Read more
- Are the recruitment targets and study design feasible?
- Is the new intervention feasible, acceptable, and appropriate?
- Does the new intervention lead to more improvements in SITBs, mental health symptoms, and treatment targets relative to treatment as usual (TAU)?
In Phase 1 (pre-implementation, months 1-6), enrolled preadolescent and caregiver dyads will receive TAU. In Phase 2 (post-implementation, months 7-13), enrolled dyads will receive the newly-developed SITB intervention. Participants will be recruited through referrals from the psychiatric emergency department at Children's Hospital Colorado. Participants will:
- Complete an initial baseline assessment to determine eligibility and assess SITBs, mental health symptoms, executive functioning, and emotion regulation
- Participate in an intervention lasting 6-12 weeks, including weekly or biweekly sessions
- Complete additional assessments at post-treatment and 3-month follow-up
- Participate in an interview sharing their perceptions of the intervention
Read the detailed description
In Stage 1 of the study (Aim 1), the investigators will iteratively design an intervention for preadolescent SITBs through a step-by-step process using frameworks for systematically developing and adapting interventions (Wingood et al., 2008; Bartholomew et al., 1998). The design process will incorporate user-centered design methods, whereby multisectoral experts and end-users (i.e., therapists and families) will participate in the design process to maximize the intervention's dissemination and implementation potential. In Stage 2 of the study (Aims 2 and 3), the new intervention will be evaluated using a quasi-experimental, pre-post implementation design including 52 preadolescents and caregiver(s), recruited through the CHCO emergency department (ED) at the Anschutz Campus.
In Stage 1, the investigators will use mixed methods approaches and user-centered design principles to iteratively develop the preadolescent SITB intervention. Through a needs assessment, the investigators will use an exploratory sequential qualitative--> quantitative mixed methods design, whereby qualitative interviews with therapists will inform the development of a quantitative survey assessing needs and experiences of therapists treating preadolescents with SITBs. Results from the therapist assessment will be integrated with findings from qualitative interviews with preadolescents and caregiversto further inform initial decisions about core functions and specific components of the intervention. During a pre-testing phase utilizing a concurrent mixed methods approach, therapists and preadolescents/families will participate in think-aloud design sessions to provide quantitative and qualitative feedback about rough intervention prototypes. An initial draft of the intervention will then be produced and reviewed by a group of experts, resulting in a second draft of the intervention and therapist training and consultation procedures. A single-arm, intervention development trial with 6 preadolescents will inform adaptations to the intervention, therapist training, and trial procedures.
In Stage 2, the investigators will evaluate the feasibility and acceptability of the study methods and intervention, implementation, and changes in SITB and mental health outcomes using a quasi-experimental, pre-post implementation design (ADAPT-ITT Step 8, Part 2). The trial will have two phases. In Phase 1 of the trial (pre-implementation, months 1-6), enrolled participants will receive treatment as usual (TAU); in Phase 2 of the trial (post-implementation, months 7-13), enrolled participants will receive the new intervention. All treatment will be delivered at the Crisis Clinic at Children's Hospital Colorado, which provides short-term (i.e., 6-12 session) outpatient crisis intervention to youth referred from the ED. Clinicians (up to N = 16) will be recruited from the Crisis Clinic to participate. During Phase 1, clinicians will provide treatment using their typical clinical practice. Prior to Phase 2, clinicians will receive training in the new intervention and will receive monthly consultation support from the developers throughout the implementation phase. Aim 2 will evaluate feasibility, acceptability, and implementation outcomes for the intervention and study procedures. Aim 3 will be to collect preliminary evidence to explore changes in SITBs, hypothesized target mechanisms of EF and emotion regulation, and mental health symptoms relative to TAU.
- Being tested
- Treatment as usual (TAU), Preadolescent SITB Intervention
- Keywords
- Preadolescents, Children, Self-Injury, Suicidal ideation and behavior, Feasibility, Pilot Trial
- Medical subject headings
- Self-Injurious Behavior, Suicidal Ideation, Behavior, Emotional Regulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Treatment as usual (TAU)Behavioural
Typical interventions Outpatient therapist would provide to a preadolescent with SITBs, based on their clinical judgement
Preadolescent SITB InterventionBehavioural
Experimental intervention developed with end-users and experts to target emotion regulation, executive functioning, and other risk factors for SITBs in preadolescents
| Study group | Role | What they receive |
|---|---|---|
| Preadolescent SITB Intervention | Experimental | Experimental intervention for preadolescent SITBs targeting executive functioning, emotion regulation, and other SITB risk factors Receives: Behavioral: Preadolescent SITB Intervention |
| Treatment as Usual (TAU) | Active comparator | Treatment as Usual provided by outpatient mental health therapist Receives: Behavioral: Treatment as usual (TAU) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of recruitment
% recruitment targets met (benchmark = 52 preadolescents enrolled within 13 months)
Measured: Calculated at enrollment
Secondary outcomes (9)
Suicidal Ideation Intensity
Measured using the Columbia Suicide and Self Injury Severity Rating Scale (C-SSRS; Posner et al., 2011), a brief interview that consists of sections that assess: suicidal ideation, ideation intensity, and suicidal behavior. The C-SSRS has strong convergent validity, sensitivity to change, predictive and incremental validity, and good internal consistency.
Measured: From enrollment to 3-month follow-up at 20 weeks
Feasibility of Retention
% participants completing treatment (benchmark =≥ 80% participants considered treatment completers)
Measured: From enrollment to the end of treatment at 8 weeks
Perceived Appropriateness of Intervention
The Intervention Appropriateness Measure (IAM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The IAM is a 4-item measure assessing the extent to which stakeholders believe an intervention or to be appropriate. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater appropriateness. The appropriateness benchmark for all reporters is set at a mean score of 4 or greater.
Measured: From enrollment to the end of treatment at 8 weeks
Perceived Feasibility of Intervention
The Feasibility of Intervention Measure (FIM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The FIM is a 4-item measures assessing the extent to which stakeholders believe an intervention to be feasible. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater feasibility. The feasibility benchmark for all reporters is set at a mean score of 4 or greater.
Measured: From enrollment to the end of treatment at 8 weeks
Perceived acceptability of intervention
The Acceptability of Intervention Measure (AIM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The AIM is a 4-item measure assessing the extent to which stakeholders believe an intervention to be acceptable. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater acceptability. The acceptability benchmark for all reporters is set at a mean score of 4 or greater.
Measured: From enrollment to the end of treatment at 8 weeks
Treatment Engagement
Number of treatment sessions completed at post-treatment, compared to prescribed or recommended number of sessions
Measured: From enrollment to post-treatment at 8 weeks
Readmission/Admission Rates
Readmission/admission rates to the psychiatric ED or inpatient psychiatric hospitalization will be evaluated via caregiver report on the Brief form of the Services Assessment for Children and Adolescents (SACA; Horwitz et al., 2001), which will be supplemented with chart review.
Measured: From enrollment to 3-month follow-up at 8 weeks
Feasibility of Measurement
% participants at each timepoint completing measures (target = ≥ 80% at each timepoint).
Measured: From enrollment to follow-up at 20 weeks
Non-Suicidal Self-Injury
Measured using an adapted version of the Self-Injurious Thoughts and Behaviors Interview (SITBI)-Short Form, Thoughts of NSSI and NSSI subscales (Nock et al., 2007), which assesses history and characteristics of NSSI thoughts and behaviors. First instance of engagement in NSSI after beginning treatment will be the outcome of most interest, but other outcomes assessed by the interview (e.g., frequency of NSSI thoughts) may be examined as well if rates of NSSI are very low.
Measured: From enrollment to 3-month follow-up at 20 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2025
- Study startDec 2026 (estimated)
- Primary completionMay 2028 (estimated)
- Study completionMay 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Self-injuryStudies of the same condition, open and under way.
- More trials run by University of Colorado, DenverThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 52 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07281365
- Sponsor's protocol ID
- 24-1783
- Other IDs
- R34MH135963
- Status last verified
- Jul 2026
- First submitted
- 1 Dec 2025
- Last updated
- 29 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: IPD from the randomized controlled trial will be shared with the NIMH National Data Archive.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Proof-of-Concept Trial of an Emotion Regulation and Executive Functioning Intervention for SITBs in Children
- ClinicalTrials.gov ID
- NCT07281365
- Acronym / sponsor ID
- 24-1783
- Keywords
- Preadolescents, Children, Self-Injury, Suicidal ideation and behavior, Feasibility, Pilot Trial
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 52 participants (estimated)
- Lead sponsor
- University of Colorado, DenverUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Study start
- Dec 2026 (estimated)
- Primary completion
- May 2028 (estimated)
- Study completion
- May 2028 (estimated)
- First posted
- 15 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs).
The main questions it aims to answer are:
- Are the recruitment targets and study design feasible?
- Is the new intervention feasible, acceptable, and appropriate?
- Does the new intervention lead to more improvements in SITBs, mental health symptoms, and treatment targets relative to treatment as usual (TAU)?
In Phase 1 (pre-implementation, months 1-6), enrolled preadolescent and caregiver dyads will receive TAU. In Phase 2 (post-implementation, months 7-13), enrolled dyads will receive the newly-developed SITB intervention. Participants will be recruited through referrals from the psychiatric emergency department at Children's Hospital Colorado. Participants will:
- Complete an initial baseline assessment to determine eligibility and assess SITBs, mental health symptoms, executive functioning, and emotion regulation
- Participate in an intervention lasting 6-12 weeks, including weekly or biweekly sessions
- Complete additional assessments at post-treatment and 3-month follow-up
- Participate in an interview sharing their perceptions of the intervention
Detailed description
In Stage 1 of the study (Aim 1), the investigators will iteratively design an intervention for preadolescent SITBs through a step-by-step process using frameworks for systematically developing and adapting interventions (Wingood et al., 2008; Bartholomew et al., 1998). The design process will incorporate user-centered design methods, whereby multisectoral experts and end-users (i.e., therapists and families) will participate in the design process to maximize the intervention's dissemination and implementation potential. In Stage 2 of the study (Aims 2 and 3), the new intervention will be evaluated using a quasi-experimental, pre-post implementation design including 52 preadolescents and caregiver(s), recruited through the CHCO emergency department (ED) at the Anschutz Campus.
In Stage 1, the investigators will use mixed methods approaches and user-centered design principles to iteratively develop the preadolescent SITB intervention. Through a needs assessment, the investigators will use an exploratory sequential qualitative--> quantitative mixed methods design, whereby qualitative interviews with therapists will inform the development of a quantitative survey assessing needs and experiences of therapists treating preadolescents with SITBs. Results from the therapist assessment will be integrated with findings from qualitative interviews with preadolescents and caregiversto further inform initial decisions about core functions and specific components of the intervention. During a pre-testing phase utilizing a concurrent mixed methods approach, therapists and preadolescents/families will participate in think-aloud design sessions to provide quantitative and qualitative feedback about rough intervention prototypes. An initial draft of the intervention will then be produced and reviewed by a group of experts, resulting in a second draft of the intervention and therapist training and consultation procedures. A single-arm, intervention development trial with 6 preadolescents will inform adaptations to the intervention, therapist training, and trial procedures.
In Stage 2, the investigators will evaluate the feasibility and acceptability of the study methods and intervention, implementation, and changes in SITB and mental health outcomes using a quasi-experimental, pre-post implementation design (ADAPT-ITT Step 8, Part 2). The trial will have two phases. In Phase 1 of the trial (pre-implementation, months 1-6), enrolled participants will receive treatment as usual (TAU); in Phase 2 of the trial (post-implementation, months 7-13), enrolled participants will receive the new intervention. All treatment will be delivered at the Crisis Clinic at Children's Hospital Colorado, which provides short-term (i.e., 6-12 session) outpatient crisis intervention to youth referred from the ED. Clinicians (up to N = 16) will be recruited from the Crisis Clinic to participate. During Phase 1, clinicians will provide treatment using their typical clinical practice. Prior to Phase 2, clinicians will receive training in the new intervention and will receive monthly consultation support from the developers throughout the implementation phase. Aim 2 will evaluate feasibility, acceptability, and implementation outcomes for the intervention and study procedures. Aim 3 will be to collect preliminary evidence to explore changes in SITBs, hypothesized target mechanisms of EF and emotion regulation, and mental health symptoms relative to TAU.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Preadolescent SITB Intervention | Experimental | Behavioral: Preadolescent SITB InterventionExperimental intervention for preadolescent SITBs targeting executive functioning, emotion regulation, and other SITB risk factors |
| Treatment as Usual (TAU) | Active comparator | Behavioral: Treatment as usual (TAU)Treatment as Usual provided by outpatient mental health therapist |
Who may qualify
- Ages
- 7 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (6 listed)
- between the ages of 7-12
- at least one caregiver/legal guardian able to participate (more permitted)
- experienced at least one episode of SITBs within the last month
- ability to attend weekly sessions in-person or via telehealth
- ability to attend baseline and post-treatment assessments in-person.
Key exclusion criteria (5 listed)
- symptoms interfering with ability to participate in assessments/therapy (i.e., psychosis)
- estimated verbal IQ<70 or previous diagnosis of intellectual development disorder
- requiring inpatient psychiatric stabilization or high-intensity intervention to prevent hospitalization
- active substance use
- ward of the state
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Treatment as usual (TAU)Typical interventions Outpatient therapist would provide to a preadolescent with SITBs, based on their clinical judgement | Behavioural | Treatment as Usual (TAU) |
| Preadolescent SITB InterventionExperimental intervention developed with end-users and experts to target emotion regulation, executive functioning, and other risk factors for SITBs in preadolescents | Behavioural | Preadolescent SITB Intervention |
Primary outcome
Feasibility of recruitment
Time frame: Calculated at enrollment
% recruitment targets met (benchmark = 52 preadolescents enrolled within 13 months)
9 secondary outcomes
Suicidal Ideation Intensity
Time frame: From enrollment to 3-month follow-up at 20 weeks
Feasibility of Retention
Time frame: From enrollment to the end of treatment at 8 weeks
Perceived Appropriateness of Intervention
Time frame: From enrollment to the end of treatment at 8 weeks
Perceived Feasibility of Intervention
Time frame: From enrollment to the end of treatment at 8 weeks
Perceived acceptability of intervention
Time frame: From enrollment to the end of treatment at 8 weeks
Treatment Engagement
Time frame: From enrollment to post-treatment at 8 weeks
Readmission/Admission Rates
Time frame: From enrollment to 3-month follow-up at 8 weeks
Feasibility of Measurement
Time frame: From enrollment to follow-up at 20 weeks
Non-Suicidal Self-Injury
Time frame: From enrollment to 3-month follow-up at 20 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2026.
- Individual participant dataSharing planned: Yes. IPD from the randomized controlled trial will be shared with the NIMH National Data Archive.
Related trials for Self-injury
Not yet recruitingPhase 1/2
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Suicide, Secure Firearm Storage
Recruiting
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
Non-suicidal Self-injury (NSSI)
Recruiting
Specialist Supportive Clinical Management (SSCM) for Children and Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa
Anorexia Nervosa, Atypical Anorexia Nervosa
Recruiting
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Depression and Suicide
Recruiting
Suicide Preventive Psychosocial Treatment for Youths
Suicide Attempt, Suicidal and Self-injurious Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Treatment as usual (TAU) and Preadolescent SITB Intervention in people with Self-injury and Suicidal Ideation and Behavior, run by University of Colorado, Denver at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of recruitment (time frame: Calculated at enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.